The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

Abstract This study aimed to prove that the FibroScan-aspartate aminotransferase (FAST) scores can be used to stratify disease severity in a Japanese cohort with fatty liver diseases [metabolic dysfunction-associated fatty liver disease (MAFLD) and nonalcoholic fatty liver disease (NAFLD)]. All the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hideki Fujii, Shinya Fukumoto, Masaru Enomoto, Sawako Uchida-Kobayashi, Tatsuo Kimura, Akihiro Tamori, Yuji Nadatani, Shingo Takashima, Naoki Nishimoto, Norifumi Kawada
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/e1ed949c073c40da8db5b7808859e73e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!